Loading patent…
AssigneeBoehringer Ingelheim International GmbH
InventorsRoland PFAU, Georg DAHMANN, Johann Faustus DU HOFFMANN, Kai GERLACH, Riccardo GIOVANNINI, Christoph HOHN, Stefan JUST, Thorsten LEHMANN, Anton PEKCEC, Julia SCHLICHTIGER, Heiko SOMMER, Christian SPECKER
Estimating the term…
The present invention relates to substituted dioxane derivatives, pharmaceutical compositions containing them and their use in therapy, particularly in the treatment and/or prevention of neuronal and non-neuronal conditions having an association with mGluR4 function and/or in the treatment of obesity by means of mGluR4 modulation.
A method for treating a disease or disorder that can be alleviated inhibiting the activity of the metabotropic glutamate receptor subtype 4 (mGluR4), comprising administering to a patient in need thereof a pharmaceutically effective amount of a compound selected from the group consisting of:
A method for treating a metabotropic glutamate receptor subtype 4 (mGluR4) mediated disorder in a subject, the method comprising administering to the subject a pharmaceutically effective amount of a compound selected from the group consisting of:
Dependencies are inferred from the claim text.